Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Barry J. Simon currently holds 2,777,788 shares of ImmunityBio, Inc. (IBRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Barry J. Simon has been a net seller of IBRX stock. They have purchased $0 and sold $15.8M worth of shares.
Barry J. Simon's most recent insider trade was on Oct 5, 2026, when they sold 25,000 shares at $10.75 per share.
Barry J. Simon serves as Executive at ImmunityBio, Inc. (IBRX). They have executed 56 insider transactions totaling $15.8M over their tenure at the company.
Barry J. Simon holds the position of Executive at ImmunityBio, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Barry J. Simon has shown a selling trading pattern, with $0 in total purchases and $15.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Barry J. Simon was on Dec 22, 2020, when they sold $2.3M worth of NK shares. This transaction involved 130,000 shares at $18.05 per share.
Barry J. Simon currently owns 2,777,788 shares of ImmunityBio, Inc. (IBRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Barry J. Simon's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Barry J. Simon has 56 Form 4 filings on record as an insider at ImmunityBio, Inc..
Set alerts for Barry J. Simon and 40,000+ other insiders.